Shanghai, China · Founded 2018 · Privately Held (backing)
Developer of gene therapy drugs designed for the treatments of rare human genetic diseases. Huidagene Therapeutics is based in Shanghai, China and was founded in 2018. It has raised $80.4 million.
Last price · $/share
—
Implied valuation
—
Total raised
$80.4M
Last round
—
Cap table — not yet on record
Huidagene Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Huidagene Therapeutics with a free account
·Watch Huidagene Therapeutics: the Monday email on marks, rounds and moves
